Amryt Pharma PLC's (LON:AMYT) Joe Wiley speaks to Proactive London's Andrew Scott as the company began trading on NASDAQ.
Wiley says he's delighted and it's a big day for the company which they've been building towards for some time.
He's hoping the move will 'enhance the value of its equity on both sides of the Atlantic' as well as broaden its analyst coverage.